Biochips Market on target to reach $21.41 Billion by 2025 : North America region to show fastest growing rates during forecast period

Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously. It can rapidly screen a number of biological analytes for an array of applications such as disease diagnosis and detection of hazardous biological agents in a system. It is designed on the basis of microarray and microfluidic technologies, among which digital microfluid biochip is highly efficient, and has gained significant popularity in the biochemical field.

According to a new report published by Allied Market Research, titled, Biochips Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 20182025," the market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025, registering a CAGR of 11.2% from 2018 to 2025.

Request Sample/ TOC Report @ https://www.alliedmarketresearch.com/request-sample/4359

Market dynamics

Increase in prevalence of cancer, immunological disorders, and viral infections majorly drives the growth of the global biochips market. Other factors that boost the market growth include rise in geriatric population, increase in number of biochip applications, and high adoption of personalized medications. However, factors such as high cost of biochip and lack of knowledge about it majorly in emerging nations hamper the market growth. Conversely, rise in R&D investment as well as government funding and high potential in untapped markets in emerging economies are expected to provide lucrative growth opportunities for the market.

Market segmentation

The global biochips market is segmented based on product, application, end user, and region. On the basis of product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. The DNA chip segment accounted for the largest market share in 2017, and is expected to continue this trend throughout the forecast period, owing to high adoption of DNA chip products. However, protein chip segment is anticipated to grow at a significant CAGR of 12.9% during the forecast period.

The applications covered in the study include drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others.

The biochips market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of life-threatening disorders, surge in number of aged people who are susceptible to cancer, increase in applications of biochips, and high demand for personalized medicines. However, high cost of biochip products and lack of knowledge about biochips hinder the market growth. On the contrary, increase in R&D investments as well as government funding and high growth potential in developing regions are expected to provide numerous opportunities for the market growth.

The DNA chip segment accounted for the largest share in 2017, owing to high availability of DNA chips as compared to other products. However, the protein chip segment is expected to grow at the high CAGR from 2018 to 2025.

The drug discovery & development segment led the global biochips market in 2017, and is expected to maintain this trend during the forecast period. On the other hand, disease diagnostics segment is anticipated to record the highest CAGR from 2018 to 2025.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4359

The utilization rate of biochips in biotechnology and pharmaceutical companies was high in 2017. However, the academic and research institutes segment is expected to grow at a CAGR of 13.5% during the forecast period.

Key findings of the Biochips Market :

• The lab-on-a-chip segment accounted for nearly 37% share of the global biochips market in 2017.
• The genomics segment is expected to grow at a CAGR of 10.6% from 2018 to 2025.
• The hospitals & diagnostics centers segment accounted for around one-fourth share of the global market in 2017.
• Europe accounted for more than one-fourth share of the global market in 2017.
• LAMEA is expected to grow at a CAGR of 11.9% from 2018 to 2025.

North America accounted for more than 40% share of the global market in 2017, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidence of cancer, growth in geriatric population, and adoption of biochips due to their wide applications. In addition, presence of high number of key players and availability of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.

For More Info Visit @ https://www.alliedmarketresearch.com/press-release/biochip-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.